2023
DOI: 10.1016/j.xkme.2023.100631
|View full text |Cite
|
Sign up to set email alerts
|

Alport Syndrome: Clinical Spectrum and Therapeutic Advances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 123 publications
0
13
0
Order By: Relevance
“…However, recent studies are questioning this statistical claim and revealing a shift in our understanding. These results are based on advancements in molecular genetic testing for ATS, and studies that estimated the frequencies of COL4A3, COL4A4, and COL4A5 PVs in sequencing databases of populations but without known neither kidney disease nor adjusting for the disease penetrance of individual variants [19][20][21]. In our population, this difference in transmission patterns can be attributed to the high rate of consanguinity in Tunisian families [22].…”
Section: Discussionmentioning
confidence: 89%
“…However, recent studies are questioning this statistical claim and revealing a shift in our understanding. These results are based on advancements in molecular genetic testing for ATS, and studies that estimated the frequencies of COL4A3, COL4A4, and COL4A5 PVs in sequencing databases of populations but without known neither kidney disease nor adjusting for the disease penetrance of individual variants [19][20][21]. In our population, this difference in transmission patterns can be attributed to the high rate of consanguinity in Tunisian families [22].…”
Section: Discussionmentioning
confidence: 89%
“…For COL4a1/a2/a3 protein expression profiles exist (The Human Protein Atlas, 2023). A defect of the α-chains COL4a3/a4/a5 can lead to Alport syndrome which affects the basement membranes of the kidney, inner ear, and eye (Gregorio et al, 2023; Imafuku et al, 2018; Shulman et al, 2021; Deltas, 2022). Although part of the bigger subnetwork of FACITs, network-forming collagens and transmembrane collagens, there is a strong bond between COL8a1/a2 and COL10a1.…”
Section: Discussionmentioning
confidence: 99%
“…At a lower threshold of 17.0, a connection between COL4 and COL7 can be seen as mentioned in the literature (Roig-Rosello and Rousselle, 2020; Brittingham et al, 2006). A defect of the α-chains COL4a3/a4/a5 can lead to Alport syndrome which affects the basement membranes of the kidney, inner ear, and eye (Gregorio et al, 2023; Imafuku et al, 2018; Shulman et al, 2021; Deltas, 2022). The second cluster is formed by COL8a1, COL8a2 and COL10a2.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 11 , 12 Furthermore, previous studies have demonstrated that the inhibition of the renin–angiotensin system reduces proteinuria and decreases the rate of glomerulosclerosis and disease progression in patients with Alport syndrome. 13 , 14 Moreover, a cohort study of nephronophthisis suggested that the use of angiotensin-converting enzyme inhibitors was an independent risk factor associated with early-onset ESRD in patients with pathological variants of NPHP1 . 15 Therefore, accurately diagnosing inherited kidney diseases may delay CKD progression and avoid RRT.…”
mentioning
confidence: 99%